Video: Jim Cramer Reacts to Biogen's Surge

Biogen shares rose 15% Friday following upbeat results from an Alzheimer's drug test.
Author:
Publish date:

Biogen shares rose 15% Friday following upbeat results from an Alzheimer's drug test.

"This is a drug that a lot of people wrote off in December of 2017 because they didn't good luck in end points for Alzheimers," said TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Want exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!